Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 9/20 | 1.00 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | APAF1 | O14727 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.52 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31145561 | 1.00 | ERN1 (1.00) | ERN1GPR35L3MBTL1MAPTKMT2A | |
| SCHEMBL29114884 | 0.98 | ERN1 (0.96) | ERN1GPR35L3MBTL1MAPTKMT2A | |
| SCHEMBL11417397 | 0.98 | ERN1 (0.96) | ERN1GPR35L3MBTL1MAPTKMT2A | |
| Potassium SCHEMBL30661194 | 0.98 | ERN1 (0.96) | ERN1GPR35L3MBTL1MAPTKMT2A | |
| SCHEMBL30661191 | 0.98 | ERN1 (0.96) | ERN1GPR35L3MBTL1MAPTKMT2A | |
| SCHEMBL29114874 | 0.98 | ERN1 (0.96) | ERN1GPR35L3MBTL1MAPTKMT2A | |
| SCHEMBL11417400 | 0.98 | ERN1 (0.96) | ERN1GPR35L3MBTL1MAPTKMT2A | |
| SCHEMBL7510757 | 0.86 | ERN1 (0.74) | ERN1GPR35L3MBTL1MAPTKMT2A | |
| 2,4-Dinitrophenol SCHEMBL10613143 | 0.85 | ERN1 (0.72) | ERN1GPR35L3MBTL1MAPTKMT2A | |
| SCHEMBL11761369 | 0.84 | ERN1 (0.72) | ERN1GPR35L3MBTL1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 835 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119680014-A | Anti-infection bone repair composite material targeting intracellular bacteria and preparation method thereof | 广东省科学院微生物研究所(广东省微生物分析检测中心) | 2025-03-25 | — | — | CN | claimed |
| CN-119192584-A | Siloxane modified terpyridine corrosion-resistant auxiliary agent and application thereof in preparation of intrinsic metal corrosion-resistant epoxy resin coating | 厦门大学深圳研究院 | 2024-12-27 | — | — | CN | claimed |
| CN-114957341-B | Spiropyran platinum complex, preparation thereof and application thereof in light-operated hand-light switch material | 杭州师范大学 | 2024-06-25 | — | — | CN | claimed |
| CN-115672261-B | Sulfhydryl Schiff base side group-containing polymer modified attapulgite and preparation method thereof | 江苏海洋大学 | 2024-02-20 | — | — | CN | claimed |
| CN-117402194-A | Preparation method of D-galactosamine hydrochloride | 安徽普利药业有限公司 | 2024-01-16 | — | — | CN | claimed |
| CN-116897930-A | Plant growth regulator containing nitro salicylaldehyde and its salt derivative | 河南省农业科学院植物保护研究所 | 2023-10-20 | — | — | CN | claimed |
| CN-114836043-B | Preparation method of UV-cured transparent antibacterial organosilicon material and product thereof | 杭州师范大学 | 2023-03-31 | — | — | CN | claimed |
| US-20220257483-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | HENKEL AG & CO. KGAA (DE) | 2022-08-18 | — | — | US | claimed |
| CN-114836043-A | Preparation method of UV-cured transparent antibacterial organosilicon material and product thereof | 杭州师范大学 | 2022-08-02 | — | — | CN | claimed |
| EP-4003286-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | Henkel AG & Co. KGaA (DE) | 2022-06-01 | — | — | EP | claimed |
| EP-0780363-B1 | Bisazo-benzofuran compounds, their use as charge carrier generating compounds | SHARP KK (JP) | 2001-09-26 | — | — | EP | claimed |
| WO-2000038634-A1 | AGENT FOR DYING KERATIN FIBERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-07-06 | — | — | WO | claimed |
| EP-0780363-A1 | Bisazo-benzofuran compounds, their use as charge carrier generating compounds and intermediates for their preparation | SHARP KABUSHIKI KAISHA (JP) | 1997-06-25 | — | — | EP | claimed |
| US-4777111-A | PHOTOLITHOGRAPHY MASKS | FAIRMOUNT CHEMICAL COMPANY, INC. (US) | 1988-10-11 | — | — | US | claimed |
| EP-0231207-A4 | CONTRAST ENHANCEMENT LAYER. | FAIRMOUNT CHEM (US) | 1988-02-16 | — | — | EP | claimed |
| EP-0231207-A1 | CONTRAST ENHANCEMENT LAYER | FAIRMOUNT CHEMICAL CO., INC. (US) | 1987-08-12 | — | — | EP | claimed |
| US-4672021-A | PHOTOLITHOGRAPHY | FAIRMOUNT CHEMICAL COMPANY (US) | 1987-06-09 | — | — | US | claimed |
| WO-1986007473-A1 | CONTRAST ENHANCEMENT LAYER | FAIRMOUNT CHEMICAL CO., INC. (US) | 1986-12-18 | — | — | WO | claimed |
| US-4026947-A | CHELATE CATALYSTS OF COBALT OR MANGANESE | RHONE-POULENC INDUSTRIES (FR) | 1977-05-31 | — | — | US | claimed |
| US-3950356-A | SYNTHESIS OF PHOTOCHROMIC INDOLINESPIROPYRANS | SAINT-GOBAIN INDUSTRIES (FR) | 1976-04-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220257483-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | KRT18, VIM, CDH1 | ERN1 2313/4885GPR35 4257/4885L3MBTL1 1459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.